The omega-3 oils producer VivoMega by GC Rieber has introduced its innovation VivoSens, which enables for the optimisation of the sensory analysis and subsequent performance of omega-3 oils.
A new publication from BfR, the German Federal Institute for Risk Assessment, concludes that omega-3 fatty acid supplements may increase risk of atrial fibrillation in those with existing or impending heart disease, with the greatest risk noted at the highest tested dose of 4g per day.
Anti-inflammatory properties of omega-3 fatty acids EPA and DHA could have the ability to regulate genes associated with obesity, a new systematic review has concluded.
The Norwegian marine ingredients producer Grøntvedt biotech has achieved the 'Friend Of The Sea’ certification from the World Sustainability Organisation, which recognises the company’s significant sustainability efforts within its production and processing methods.
A new umbrella review of meta-analyses investigating the effect of long-chain omega-3 supplementation on depressive symptoms concludes the majority of studies observe a significant effect, particularly in those with major depressive disorder (MDD).